RECRUITINGOBSERVATIONAL
Alpha-synuclein Rt-quic and Neurologic Symptoms in Persons With idiOpathic anosMiA
About This Trial
Test of early warning signs and RT-QuIC in patients with idiopathic olfactory dysfunction
Who May Be Eligible (Plain English)
Inclusion criteria with patients iOD:
- Age 55 -75 years of age
- Slowly progressing and non-fluctuating iOD
- Able to give willing to sign a consent form and to cooperate as evaluated by the PI
Exclusion criteria with patients iOD:
- Diagnosed with a neurodegenerative disease or major neurological/psychiatric condition.
- Anosmia/hyposmia caused by sino-nasal disease (including chronic rhinitis and allergy), after trauma, infection, congenial, olfactory dysfunction due to surgery, or toxins/drugs affecting the olfactory function.
- Olfactory dysfunction with response to systemic or local corticosteroids if tried
- Severe nasal cavity abnormalities or infections.
- Overt signs of dementia or PD
- Current alcohol or drug abuse
- Terminal illness
- Diagnosed with neurodegenerative disease or major neurological/psychiatric condition.
Inclusion criteria controls:
- Age 55 -75 years of age
- Able to give willing to sign a consent form
- Able to cooperate as evaluated by the PI
Exclusion criteria controls:
- Olfactory dysfunction on clinical test
- Overt signs of dementia or PD
- Severe nasal cavity abnormalities or infections.
- Current alcohol or drug abuse
- Diagnosed with neurodegenerative disease or major neurological/psychiatric condition.
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion criteria with patients iOD:
* Age 55 -75 years of age
* Slowly progressing and non-fluctuating iOD
* Able to give informed consent and to cooperate as evaluated by the PI
Exclusion criteria with patients iOD:
* Diagnosed with a neurodegenerative disease or major neurological/psychiatric condition.
* Anosmia/hyposmia caused by sino-nasal disease (including chronic rhinitis and allergy), after trauma, infection, congenial, olfactory dysfunction due to surgery, or toxins/drugs affecting the olfactory function.
* Olfactory dysfunction with response to systemic or local corticosteroids if tried
* Severe nasal cavity abnormalities or infections.
* Overt signs of dementia or PD
* Current alcohol or drug abuse
* Terminal illness
* Diagnosed with neurodegenerative disease or major neurological/psychiatric condition.
Inclusion criteria controls:
* Age 55 -75 years of age
* Able to give informed consent
* Able to cooperate as evaluated by the PI
Exclusion criteria controls:
* Olfactory dysfunction on clinical test
* Overt signs of dementia or PD
* Severe nasal cavity abnormalities or infections.
* Current alcohol or drug abuse
* Diagnosed with neurodegenerative disease or major neurological/psychiatric condition.
Treatments Being Tested
DIAGNOSTIC_TEST
RT-QuiC
RT-QuIC measures the ability of aSyn to misfold other aSyn proteins and is an amplification technique.
Locations (2)
Danish Dementia Research Centre
Copenhagen, Denmark
Oskar McWilliam
Copenhagen, Denmark